| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 21 |
| 1 | IBRUTINIB | 19 |
| 2 | DABIGATRAN ETEXILATE MESYLATE | 17 |
| 3 | PREDNISONE | 17 |
| 4 | DABIGATRAN ETEXILATE | 16 |
| 5 | NATALIZUMAB | 16 |
| 6 | ACETAMINOPHEN 500MG | 15 |
| 7 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 15 |
| 8 | ADALIMUMAB | 15 |
| 9 | OMEPRAZOLE MAGNESIUM | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MIGLUSTAT | 4 | 0.0034 |
| 1 | REVUMENIB | 3 | 0.0029 |
| 2 | DARIDOREXANT | 8 | 0.0029 |
| 3 | LOTEPREDNOL ETABONATE AND TOBRAMYCIN | 1 | 0.0025 |
| 4 | ELAFIBRANOR | 2 | 0.0022 |
| 5 | PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0016 |
| 6 | ORPHENADRINE CITRATE | 1 | 0.0016 |
| 7 | PEXIDARTINIB HYDROCHLORIDE | 1 | 0.0014 |
| 8 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0013 |
| 9 | DUVELISIB | 1 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 34 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30 |
| 2 | Kinase Inhibitor [EPC] | 28 |
| 3 | Benzodiazepine [EPC] | 23 |
| 4 | Factor Xa Inhibitor [EPC] | 20 |
| 5 | Atypical Antipsychotic [EPC] | 19 |
| 6 | Proton Pump Inhibitor [EPC] | 17 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 17 |
| 8 | Integrin Receptor Antagonist [EPC] | 16 |
| 9 | BCL-2 Inhibitor [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Enzyme Stabilizer [EPC] | 4 | 0.0034 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 2 | 0.0022 |
| 3 | Glucosylceramide Synthase Inhibitor [EPC] | 4 | 0.0014 |
| 4 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 5 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 6 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 7 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 5 | 0.0007 |
| 8 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 9 | Stimulant Laxative [EPC] | 9 | 0.0006 |